Working together to reduce the global burden of kidney cancer
Kidney cancer is a global issue. Every year, 431,000 people worldwide will be diagnosed with kidney cancer.
Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.
The 2024 IKCC Global Patient Survey is Now Open!
The 4th Global Patient Survey on Kidney Cancer and Kidney Growths (GPS) is now open until 15 November.
Together with Partner Organisations, we’re calling on anyone who has experience with kidney cancer or kidney growths to complete the survey. This includes people who have received a diagnosis or is a caregiver. The information gathered helps create education, awareness and advocacy programs that accurately respond to the needs of people affected by kidney cancer.
EMSO 2024 Summary of Kidney Cancer Highlights
We were at ESMO Congress 2024 in Barcelona, Spain in September for Europe’s premier oncology conference where new data, research findings and education were presented.
Members of the IKCC Medical Advisory Board have created a patient-friendly summary of the ESMO Congress presentations related to kidney cancer treatment. It’s our goal to help support patient organisations, and in turn patients and carers, by sharing the best and most up-to-date information about kidney cancer available. The ESMO Congress 2024 Highlights Summary can be found here.
2024 World Kidney Cancer Day Launched!
World Kidney Cancer Day launched on Thursday 20th June 2024 to great success. The campaign is focused on helping patients and healthcare professionals have better conversations.
The campaign is now live at www.worldkidneycancerday.org where you can find social media content and downloadable resources in 15 languages. Thanks to all Partner Organisations and members of the kidney cancer community who made this year’s campaign a great success!
#WorldKidneyCancerDay24
Tweets from @IKCCorg
;
Affiliates of the @IKCCorg went to the ESMO 2024 meeting and prepared the #kidneycancer summary for the benefit of patient advocates and patient organisations around the world . See summary at this link: https://www.kidneycancercanada.ca/news/summary-of-kidney-cancer-highlights-from-esmo-2024/
L'@IKCCorg s'est rendu à l'ESMO 2024 et a rédigé un résumé des présentations sur le #cancerdurein à l’intention des défenseurs des droits des patients et des organisations de patients du domaine du cancer du rein partout dans le monde: https://www.cancerdurein.ca/news/resume-des-faits-saillants-sur-le-cancer-du-rein-de-lesmo-2024/
We’re highlighting more updates from the European Society for Medical Oncology (ESMO) meeting, brought to you by the @IKCCorg! These updates will inform new treatments and improve patient outcomes with #KidneyCancer
🔗 https://bit.ly/Esmo2024
#AcceleratingCures
Ekpf and @IKCCorg have launched the 2024 Global Patient Survey on Kidney Cancer and Growths! Calling all #kidneycancer patients, carers and survivors to share their experiences and insights in this 15-minute online survey.🖋️ https://bit.ly/ikcc2024GPS
#ICYMI: Our discussion on the connection between #KidneyDisease and #KidneyCancer is available now on our Youtube Channel!
Watch now! 🔗 https://bit.ly/KidneyCANandNFK
#AcceleratingCures
Exciting updates from the @IKCCorg, who recently reviewed research presented at the prestigious European Society for Medical Oncology (ESMO) conference in Barcelona. Here are only SOME of the highlights relevant to #KidneyCancer!
🔗https://bit.ly/Esmo2024
#AcceleratingCures
Did you know?
Kidney cancer is often found by accident.
Kidney cancer is the 14th most prevalent cancer worldwide.
About 59 per cent of kidney cancer cases occur in more developed countries.
Our Global Network
IKCC welcomes every organisation that has an interest in kidney cancer and who pledges to conform to our Code of Conduct. We extend an open invitation to become part of this international network.
Join our mailing list
In the newsletter we highlight news about kidney cancer diagnosis and treatment, and other relevant discussions.